sulfamethoxypyridazine has been researched along with Cyanosis in 2 studies
Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.
Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| THAL, W | 1 |
| WERNER, U | 1 |
| Stavem, P | 1 |
| Strömme, J | 1 |
| Lorkin, PA | 1 |
| Lehmann, H | 1 |
2 other studies available for sulfamethoxypyridazine and Cyanosis
| Article | Year |
|---|---|
[METHEMOGLOBINEMIAS OF YOUNG INFANTS DUE TO SULFAMETHOXYPYRIDAZINE].
Topics: Bronchitis; Cyanosis; Dyspepsia; Infant; Infant, Newborn; Meningitis; Methemoglobinemia; Sulfamethox | 1964 |
Haemoglobin M Saskatoon with slight constant haemolysis, markedly increased by sulphonamides.
Topics: Adult; Blood Protein Electrophoresis; Chromatography, Ion Exchange; Cyanides; Cyanosis; Hemoglobins, | 1972 |